CN104383011A - 一种治疗胆囊结石中药配方 - Google Patents
一种治疗胆囊结石中药配方 Download PDFInfo
- Publication number
- CN104383011A CN104383011A CN201410628613.XA CN201410628613A CN104383011A CN 104383011 A CN104383011 A CN 104383011A CN 201410628613 A CN201410628613 A CN 201410628613A CN 104383011 A CN104383011 A CN 104383011A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- cholelithiasis
- traditional chinese
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 208000001130 gallstones Diseases 0.000 title abstract description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 201000001883 cholelithiasis Diseases 0.000 claims description 28
- 241000628997 Flos Species 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 239000004575 stone Substances 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000002175 menstrual effect Effects 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001571764 Lysimachia christinae Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000030761 polycystic kidney disease Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000026372 Congenital cystic kidney disease Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002504 lithotomy Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗胆囊结石的中药配方，由下述原料按重量份组成：红花5-15份、白芍10-20份、金钱草5-15份、连翘15-25份、荷叶10-20份、半连枝10-20份。本发明的治疗胆囊结石的中药，具有通经舒络、活血化瘀、清热利湿、消炎止痛、软坚破结、降脂溶石、增加液汁分泌囊壁收缩功能，不断推挤结石下移，达到快速将结石排出体外的作用。
Description
【技术领域】
本发明属于医药领域，尤其属于一种治疗胆囊结石的中药配方。
【技术背景】
胆囊结石是一种常见的疾病，一般见多发生在中壮年，男性多于女性，半数以上患者在发生多囊肾同时合并胆囊结石，部分患者同时有胆结石发生，一般来讲胆囊结石多由尿内盐类沉淀凝集而成，其主要成分有尿酸盐、草酸盐等，主要症状为肾绞痛、血尿。胆囊结石可分为含钙胆囊结石、尿酸结石、感染性结石等。含钙胆囊结石以草酸钙和磷酸钙为主，占全部尿结石的80％-84％。其他罕见结石，如长期用药引起的结石，服用磺胺类药物最易形成结晶的是磺胺嘧啶，如辅以碱化尿液药物或多饮水，可防止磺胺结晶形成。多囊肾患者合并的胆囊结石现在具体发病机理还不清楚，但较高的发病率来讲，可能是尿酸类物质的肾内长期积累结晶所致。
胆囊结石的治疗主要包括药物排石和手术取石。药物排石能够在一定程度上消炎止痛，确实有缓解症状的作用，进口药物也能够缓解症状，但都不能够完全根除，因百排石效果都不明显。而手术取石疗法以其痛苦大、费用高，一般不被患者所接受且手术无法消除形成结石的原因，因此手术后极容易复发再生结石，不少病例需要再次手术，而采取碎石机体外震波碎石造成局部粘膜严重损伤几不可避免，这些因素均不利于结石的治疗。
【发明内容】
为了解决标本兼治，彻底治愈胆囊结石的问题，本发明提出了一种治疗胆囊结石的中药配方药物，经临床使用论证，该药物不仅可以在使用时缓解症状，而且，使用后即可彻底治愈胆囊结石，效果特别显著，安全无毒副作用。
为了实现上述发明目的，本发明是通过以下技术方案来实现的：
1、一种治疗胆囊结石的中药配方，由下所述中药组合物的药效成分由如下原料制备而成：红花、白芍、金钱草、连翘、荷叶、半连枝。
2、一种治疗胆囊结石的中药配方，由下所述中药组合物的药效成分由如下重量份的原料制备而成：红花5份、白芍10份、金钱草5份、连翘15份、荷叶10份、半连枝10份。
3、一种治疗胆囊结石的中药配方，所述中药组合物的药效成分由如下重量份的原料制备而成：红花5-15份、白芍10-20份、金钱草5-15份、连翘15-25份、荷叶10-20份、半连枝10-20份。
4、一种治疗胆囊结石的中药配方，其进一步优选方案的中药组合物的药效成分由如下重量份的原料制备而成：红花15份、白芍20份、金钱草15份、连翘25份、荷叶20份、半连枝20份。
5、一种治疗胆囊结石的中药配方，其中药的制备方法是：将上述药材加水量是总药量的2-3倍，煎煮2-3小时，过滤得到药汁。
本发明所提供的一种用于治疗胆囊结石的药物，具有通经舒络、活血化瘀、清热利湿、消炎止痛、软坚破结、降脂溶石、增加液汁分泌囊壁收缩功能，不断推挤结石下移，达到快速将结石排出体外的作用。
【具体实施方式】
经过一年多对100例胆囊结石病症的临床应用，取得了较好的疗效，其显著效率达95％，总有效率达98％，有关临床治疗情况详述如下：
1、病人来源：以南宁市中医院患者和专业门诊医院患者。
2、病人概况：选择病史、病情、年龄、性别及原始治疗方法等项目。
3、病例入组标准，依照胆囊结石患者的临床表现和病理特征分，性别、年龄不限，病程1周-1年以上，治疗前停用各种其它治疗胆囊结石的药物和治疗方式。
4、用药方法：患者饭后服用煎煮好的中药，每晚一次，一周为1个疗程，直至痊愈。
5、疗效分析：
1)性别：按照入组标准，我们共治疗胆囊结石患者100例，其中男性60例(60％)，女性40例(40％)。
2)病程：1周-1个月20例，1个月-3个月30例，3个月以上为50例。
3)年龄组16-20岁5例，21-30岁10例，31-40岁30例，41-50岁30例，51-60岁15例，60岁以上10例。
4)疾病类型与疗效：见下表，用药时间为1-3个疗程。
| 痊愈 | 显著 | 有效 | 无效 | |
| 轻度患者50例 | 48 | 2 | 0 | 0 |
| 一般患者30例 | 27 | 1 | 1 | 1 |
| 重症患者20例 | 17 | 1 | 1 | 1 |
虽然，上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述，但在本发明基础上，可以对之作一些修改或改进，这对本领域技术人员而言是显而易见的。因此，在不偏离本发明精神的基础上所做的这些修改或改进，均属于本发明要求保护的范围。
Claims (6)
1.一种治疗胆囊结石的中药配方，其特征在于，所述中药组合物的药效成分由如下原料制备而成：红花、白芍、金钱草、连翘、荷叶、半连枝。
2.一种治疗胆囊结石的中药配方，其特征在于，所述中药组合物的药效成分由如下重量份的原料制备而成：红花5-15份、白芍10-20份、金钱草5-15份、连翘15-25份、荷叶10-20份、半连枝10-20份。
3.一种治疗胆囊结石的中药配方，其特征在于，所述中药组合物的药效成分由如下重量份的原料制备而成：红花5份、白芍10份、金钱草5份、连翘15份、荷叶10份、半连枝10份。
4.一种治疗胆囊结石的中药配方，其特征在于，所述中药组合物的药效成分由如下重量份的原料制备而成：红花10份、白芍15份、金钱草10份、连翘20份、荷叶15份、半连枝15份。
5.一种治疗胆囊结石的中药配方，其特征在于，所述中药组合物的药效成分由如下重量份的原料制备而成：红花15份、白芍20份、金钱草15份、连翘25份、荷叶20份、半连枝20份。
6.一种治疗胆囊结石的中药配方，其特征在于，中药的制备方法是：将上述药材加水量是总药量的2-3倍，煎煮2-3小时，过滤得到药汁。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410628613.XA CN104383011A (zh) | 2014-11-11 | 2014-11-11 | 一种治疗胆囊结石中药配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410628613.XA CN104383011A (zh) | 2014-11-11 | 2014-11-11 | 一种治疗胆囊结石中药配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104383011A true CN104383011A (zh) | 2015-03-04 |
Family
ID=52601035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410628613.XA Pending CN104383011A (zh) | 2014-11-11 | 2014-11-11 | 一种治疗胆囊结石中药配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104383011A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168404A (zh) * | 2015-10-28 | 2015-12-23 | 陈岳良 | 一种治疗胆囊结石的中药 |
| CN106138542A (zh) * | 2015-04-13 | 2016-11-23 | 张金桃 | 一种治疗胆囊结石的中药 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879693A (zh) * | 2006-05-16 | 2006-12-20 | 成都市武侯专利咨询研发转化研究所 | 治疗胆结石症的药物 |
| CN103031229A (zh) * | 2011-10-01 | 2013-04-10 | 张玉华 | 一种红花排石酒及泡制方法 |
| KR20130129523A (ko) * | 2012-05-21 | 2013-11-29 | 정대희 | 담결석 치료제 한약 제조방법. |
-
2014
- 2014-11-11 CN CN201410628613.XA patent/CN104383011A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879693A (zh) * | 2006-05-16 | 2006-12-20 | 成都市武侯专利咨询研发转化研究所 | 治疗胆结石症的药物 |
| CN103031229A (zh) * | 2011-10-01 | 2013-04-10 | 张玉华 | 一种红花排石酒及泡制方法 |
| KR20130129523A (ko) * | 2012-05-21 | 2013-11-29 | 정대희 | 담결석 치료제 한약 제조방법. |
Non-Patent Citations (3)
| Title |
|---|
| 《中国民族药志》编委会: "《中国民族药志.第4卷》", 31 December 2007, 四川民族出版社 * |
| 叶德强等: "荷叶提取物黄酮对兔胆囊结石形成的影响", 《江西医药》 * |
| 王秀君: "茵陈退黄饮治疗疑难黄疸86例体会", 《黑龙江中医药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106138542A (zh) * | 2015-04-13 | 2016-11-23 | 张金桃 | 一种治疗胆囊结石的中药 |
| CN105168404A (zh) * | 2015-10-28 | 2015-12-23 | 陈岳良 | 一种治疗胆囊结石的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101732621A (zh) | 治疗肾结石的中药 | |
| CN103316315B (zh) | 一种退热贴 | |
| CN104383011A (zh) | 一种治疗胆囊结石中药配方 | |
| CN104337872A (zh) | 一种治疗尿路结石的中药配方 | |
| CN104095970A (zh) | 一种治疗寻常疣的外敷药酒 | |
| CN103736025B (zh) | 一种跌打生肌膏 | |
| CN105497163A (zh) | 一种治疗肾结石的中药配方 | |
| CN101810668A (zh) | 拔毒膏药 | |
| CN1286515C (zh) | 一种治疗囊肿的药物组合物 | |
| CN102949672A (zh) | 一种治疗盆腔炎的药物 | |
| CN106138719A (zh) | 一种治疗尿结石的中药配方 | |
| CN113491739B (zh) | 治疗子宫内膜异位症的止痛消癥散结中药及其制作方法 | |
| CN101983681A (zh) | 一种治疗白带异常的药剂 | |
| CN106552115A (zh) | 一种治疗胆囊结石的中药 | |
| CN106138542A (zh) | 一种治疗胆囊结石的中药 | |
| CN107432901A (zh) | 一种治疗肾结石的中药 | |
| CN101744897A (zh) | 治疗急慢性湿疹的外用药物制剂 | |
| CN105853547A (zh) | 一种治疗慢性鼻炎的中药组合物 | |
| CN105663514A (zh) | 一种治疗慢性鼻炎的中药组合物 | |
| CN104800632A (zh) | 一种治疗肾结石的中药组合物 | |
| CN104689121B (zh) | 一种治疗外阴瘙痒的药剂的制备方法 | |
| CN104689122B (zh) | 一种治疗外阴瘙痒的药剂 | |
| CN104491327A (zh) | 一种用于治疗褥疮的喷雾药剂 | |
| CN104758346A (zh) | 一种治疗偏头痛的药物及其制备方法、制剂 | |
| CN103751619A (zh) | 一种金钱草排石茶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150304 |
|
| RJ01 | Rejection of invention patent application after publication |